HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

1,273.992

-6.251-0.49%

Number of Gainers:8

Number of Losers:6

Number of Flat:4

PE:- -

High:1,300.387

Open:1,280.378

Low:1,269.834

Close:1,280.243

Volume:266.08M

Turnover:2.44B

Market Cap:851.51B

Float Cap:715.89B

Loading ...

TRAD CHI MED Reports First Loss in a Decade with Net Profit Plummeting Over 2000%

Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China

MT Newswires Live

Is It Reasonable to Prohibit Teachers from Applying to Other Employers?

AH Share Premium Rankings as of February 25

Liu Qiangdong's $5 Billion Yacht Venture: A Misinterpreted "Midlife Romance"

CSPC Pharma Retains "Outperform" Rating with HK$13.07 Target from Haitong International

Antengene-B Shares Surge Over 6% Following Clinical Collaboration Agreement with Junshi Bio

Fosun Pharmaceutical Amends Drug Licensing Agreements

MT Newswires Live

Waterdrop's Yifan Pharma Deploys China's First AI-Powered Patient Matching Patent for Clinical Trials

Liu Qiangdong Secures Five Yacht Orders Averaging 486 Million Yuan Each

JPMorgan Increases Stake in SINOPHARM with Purchase of Approximately 347,233 Shares

Pharmaceutical Licensing Deals Surge as Domestic R&D Capabilities Strengthen

CANSINOBIO's Meningococcal Vaccine Menhycyte™ Receives Expanded Age Indication Approval

JD Health International Stock Falls 2.1% in Hong Kong

CSPC Pharmaceutical Group Stock Slips 5.2% in Hong Kong

Sino Biopharmaceutical Stock Slides 6.6% in Hong Kong, Underperforms Competitors

CSPC Pharma's AstraZeneca Deal Suggests Undervalued Drug Pipeline -- Market Talk

AH Premium Rankings for February 24th

Zhejiang Medicine to Invest in Partnership Fund Targeting Silver Economy and Healthcare Sector

Xuanzhu Biopharmaceutical to Join Hang Seng Index

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1515/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":1273.9922,"timestamp":1772006913275,"preClose":1280.2434,"halted":0,"volume":266075580,"delay":0,"changeRate":-0.004883,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-6.251221,"latestTime":"02-25 16:00:00","open":1280.3783,"high":1300.3865,"low":1269.8336,"amount":2436477198,"amplitude":0.023865,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772069400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1771983000000,1771992000000],[1771995600000,1772006400000]],"pbRate":2.292659,"peRate":24.382648,"turnoverRate":0.003395,"increases":8,"decrements":7,"flats":2,"marketCap":851507405568,"floatMarketCap":715889019264},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1300.3865,"amplitude":0.023865,"preClose":1280.2434,"low":1269.8336,"pbRate":"2.292659","latestPrice":1273.9922,"volume":266075580,"delay":0,"open":1280.3783,"prevYearClose":1190.107,"prevWeekClose":1300.604,"prevMonthClose":1330.61,"prevQuarterClose":1190.107,"fiveDayClose":1311.812,"twentyDayClose":1347.994,"sixtyDayClose":1283.566,"secType":"PLATE","market":"HK","turnoverRate":0.003395,"peRate":24.382648,"marketCap":851507405568,"floatMarketCap":715889019264,"timestamp":1772006913275,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":8,"down":6,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1161535148","title":"TRAD CHI MED Reports First Loss in a Decade with Net Profit Plummeting Over 2000%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161535148","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161535148?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:02","pubTimestamp":1772031773,"startTime":"0","endTime":"0","summary":"A leading company in the traditional Chinese medicine sector has reported its first annual loss in ten years. On January 27, TRAD CHI MED issued a rare profit warning, forecasting a shift from profit...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1606","00570","BK1515"],"gpt_icon":0},{"id":"2614045081","title":"Shanghai Fosun Pharmaceutical Units Trial Nod for Lung Cancer Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045081","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614045081?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:23","pubTimestamp":1772022189,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical  unit Shanghai Fosun Pharmaceutical Industrial Development obtained clinical trial approval for Luvometinib Tablets from China's National Medical Products Administration, according to a Wednesday Hong Kong bourse filing.The drug will be tested in combination with Anlotinib for the treatment of patients with KRAS-mutant advanced non-small cell lung cancer.The subsidiary intends to begin the phase II study in China when the relevant conditions are fulfilled.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0012","BK0060","BK0175","BK0183","BK0188","02196","BK0239","BK0196","BK0096","BK1593","BK0028","BK0187","600196","BK1515","BK1191"],"gpt_icon":0},{"id":"1167930819","title":"Is It Reasonable to Prohibit Teachers from Applying to Other Employers?","url":"https://stock-news.laohu8.com/highlight/detail?id=1167930819","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167930819?lang=en_us&edition=fundamental","pubTime":"2026-02-25 19:52","pubTimestamp":1772020373,"startTime":"0","endTime":"0","summary":"A recent incident at a private school in Sanya City, Hainan, where a teacher's employment contract was terminated for applying to another institution without the school's approval, has sparked public...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","BK1515","BK1584","BK1501","BK1502","BK1142","BK1571","BK1591","BK1589","BK1610","00241","BK1189","BK1615","BK1247"],"gpt_icon":0},{"id":"1173309936","title":"AH Share Premium Rankings as of February 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1173309936","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173309936?lang=en_us&edition=fundamental","pubTime":"2026-02-25 16:21","pubTimestamp":1772007697,"startTime":"0","endTime":"0","summary":"As of the market close on February 25, NE ELECTRIC (00042), Zhejiang Shibao Company Limited (01057), and SINOPEC SSC (01033) recorded the highest AH share premium rates, at 550.60%, 337.32%, and...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0821914370.USD","603986","LU0611395673.USD","LU1282649810.SGD","LU0348814723.USD","LU1211504680.USD","LU1993786604.SGD","IE00BZ08YS42.EUR","LU1115378108.SGD","LU2778985437.USD","LU0862451753.SGD","LU2125910500.SGD","LU0856984785.SGD","LU1048588211.SGD","LU0345780281.USD","LU1242518931.SGD","LU0488056044.USD","HK0000352382.USD","LU2226246903.HKD","LU0348735423.USD","BK1592","LU0605514214.HKD","LU0164880469.USD","LU0384037296.USD","BK1116","LU0791590937.USD","BK1501","LU0165289439.USD","LU0651946864.USD","LU0865486749.SGD","IE00BZ08YT58.USD","LU0359201885.HKD","LU0106252389.USD","LU0572944931.SGD","BK1506","BK1141","LU0502904849.HKD","LU1769817179.HKD","LU0163747925.USD","LU0328353924.USD","LU0640798160.USD","LU1146622755.USD","HK0000352291.HKD","IE00B0169L03.USD","LU0828237510.HKD","BK1544","LU1282648689.USD","BK1214","LU0543330566.HKD","LU1481107354.HKD","LU0594300179.USD","LU0181495838.USD","LU0293314216.USD","IE00BVYPNP33.GBP","002703","LU0049112450.USD","LU0049853897.USD","01057","LU0244354667.USD","LU0588545730.USD","LU1251922891.USD","LU1282649067.USD","LU0315178854.USD","LU0287142896.SGD","LU0594300419.USD","LU0164872284.USD","LU1051768304.USD","LU0823426308.USD","03145","LU1366334651.USD","PNGAY","LU2424517915.HKD","IE00B031HY20.USD","LU0052750758.USD","LU0307460666.USD","SG9999000459.SGD","IE00BGHQDM52.EUR","LU0890818403.SGD","LU1044875133.USD","LU1981816686.USD","LU0315179316.USD","SG9999002463.SGD","PAImain","BK1550","LU0651947912.USD","LU0784639295.USD","BK1543","159982","LU0345780521.USD","LU1044874839.SGD","LU0106959298.USD","LU0819123356.HKD","IE00BF5LJ272.USD","LU0456827905.SGD","LU0456846285.SGD","HK0000320264.USD","LU0531971595.HKD","LU1504937902.USD","LU1282649141.HKD","LU0455707207.USD","LU0898667661.SGD","LU0235996351.USD","LU0043850808.USD","BK1198","LU1282651121.HKD","LU0918141705.HKD","LU1820825898.SGD","LU1046422090.SGD","SG9999002828.SGD","LU0140636845.USD","IE00BMCWC346.EUR","LU1226287529.USD","BK1237","LU1688375341.USD","LU0084288322.USD","LU1807302812.USD","LU0516423091.SGD","BK1202","LU0441854154.USD","LU1515016050.SGD","LU0463099449.HKD","LU0348788117.USD","SG9999002562.SGD","600871","BK1149","BK1546","LU0348783233.USD","LU1048596156.SGD","IE00B543WZ88.USD","LU2097828805.USD","LU0737861772.HKD","IE00B5MMRT66.SGD","LU0054450605.USD","BK1515","03986","LU2153592121.USD","LU0072462343.USD","LU0228367735.SGD","BK1171","LU0516422440.USD","BK1110","BK1148","LU0326950275.SGD","BK1174","BK1610","LU0708995583.HKD","SG9999004220.SGD","LU0370786039.SGD","HK0000320223.HKD","LU0228659784.USD","LU0266512473.USD","LU1831875114.USD","LU0648948544.HKD","LU1235295612.USD","LU2242644610.SGD","IE00B29SXG58.USD","BK1551","IE0008368742.USD","LU0327786744.USD","LU0882747503.HKD","BK1564","IE00B3M56506.USD","LU0828237940.HKD","LU1224444064.USD","03750","LU1282651048.USD","BK1505","LU2543165471.USD","LU0831093199.SGD","LU0449515922.USD","LU0791591158.USD","LU0348816934.USD","LU0862451837.USD","LU0561508036.HKD","LU1051769294.HKD","LU1044876610.USD","LU1720050803.USD","LU0210527791.USD","LU0417516902.SGD","IE00BVYPNQ40.USD","BK1576","LU0630378692.HKD","LU1303224171.USD","LU0229945570.USD","LU0197773673.USD","SG9999006597.SGD","BK1523","BK1507","LU0117841782.USD","LU1961090484.USD","LU0650527681.SGD","IE00BZ08YR35.GBP","BK1240","BK1554","LU1960683339.HKD","LU2097828631.EUR","BK1105","LU0348784397.USD","LU0634319403.HKD","LU0675040207.SGD","LU0540923850.HKD","LU0878005551.USD","LU0762542818.HKD","LU0819121731.USD","LU0164939612.USD","IE00B031J352.USD","BK1229","LU0417516738.SGD","LU0211977185.USD","LU2097828714.EUR","LU0593848301.USD","BK1183","LU0117844026.USD","LU2399975544.HKD","LU0516422366.SGD","IE0034224299.USD","LU1675838814.USD","LU0620787316.HKD","IE0008369823.USD","SG9999001903.USD","LU0197773160.USD","LU2293587155.HKD","HK0000306701.USD","LU1880383366.USD","LU0417516571.SGD","LU0039217434.USD","IE0031814852.USD","HPAD.SI","LU0314109678.HKD","LU0886674414.USD","HK0000306685.HKD","LU3063872942.SGD","LU0149534421.HKD","IE00BPRC5H50.USD","LU2039709279.SGD","LU0359201612.USD","BK1594","LU0880133367.SGD","LU1366334578.USD","LU0348825331.USD","LU1242518857.USD","LU2348773727.SGD","SG9999014674.SGD","LU0348783662.USD","LU2152927971.USD","LU0516422952.EUR","LU1152091754.HKD","BK1163","600036","LU1880383440.USD","82318","LU0359202008.SGD","01033","LU0516423174.USD","LU0082770016.USD","IE0003895053.USD","LU0456854461.SGD","LU0266512127.USD","LU1769817096.USD","LU0823426480.USD","LU0501845795.SGD","LU1808992512.USD","399300","LU0588545490.SGD","LU0737861699.HKD","LU0011963245.USD","LU0979878070.USD","LU2097828474.EUR","03143","LU1008478684.HKD","LU1224709979.USD","LU0061477393.USD","LU0469268626.HKD","LU2476274308.USD","LU2476274720.SGD","BK1574","LU0589944569.HKD","LU0588546209.SGD","LU0878004406.USD","LU2045819591.USD","LU0320764599.SGD","LU1719994722.HKD","LU2348774022.SGD","LU0607220059.USD","LU0871576103.HKD","LU0254981946.USD","LU1023057109.AUD","LU1188198961.HKD","BK1258","LU0173614495.USD","LU0196878994.USD","LU1770034418.SGD","601318","LU0762540952.USD","LU0762541174.USD","LU1813983027.USD","LU0048580855.USD","BK1583","LU0588545904.SGD","LU0067412154.USD","IE00BYV24P56.USD","BK1144","BK1223","LU0431992006.USD","00042","LU0329678170.USD","LU0918141887.USD","LU0096374516.USD","LU2097828557.USD","BK1184","LU1328277881.USD","LU0868486357.SGD","LU0082770016.SGD","BK1514","BK1535","LU1152091168.USD","BK1231","BK1124","LU0329678337.USD","LU0797268264.HKD","BK1521","CIHKY","LU0348827113.USD","BK1161","LU1105468828.SGD","LU1655091459.SGD","LU2153591404.USD","LU0348805143.USD","BK1560","LU0164865239.USD","LU0231483743.USD","LU0051755006.USD","LU0831103253.SGD","BK1562","03968","BK1191","300750","BK1147","LU1642822792.SGD","LU0149721374.USD","LU0630378429.USD","LU0072913022.USD","LU1794554557.SGD","BK1522"],"gpt_icon":1},{"id":"1173263192","title":"Liu Qiangdong's $5 Billion Yacht Venture: A Misinterpreted \"Midlife Romance\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1173263192","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173263192?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:22","pubTimestamp":1772000554,"startTime":"0","endTime":"0","summary":"Shortly after the 2026 Spring Festival, news spread rapidly: Liu Qiangdong has invested 5 billion yuan to establish the independent yacht brand Sea Expandary, targeting the global luxury private...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0032431581.USD","SG9999002562.SGD","BK4503","BK4220","LU0531971595.HKD","LU0345775950.USD","LU1282649067.USD","KJD","LU1720050803.USD","LU1688375341.USD","BK4558","LU0594300419.USD","LU0048580855.USD","LU1366334578.USD","LU0164880469.USD","LU1282651121.HKD","IE00B29SXG58.USD","LU0359201885.HKD","LU0320764755.SGD","LU0463099449.HKD","LU0348735423.USD","BK1589","LU0456827905.SGD","LU0084288322.USD","LU0588545904.SGD","IE00B3M56506.USD","LU0868486357.SGD","LU0315178854.USD","LU0456846285.SGD","BK1583","BK4579","LU0488056044.USD","LU0370786039.SGD","LU2257852520.SGD","LU1770034418.SGD","BK4509","HK0000306701.USD","LU0326950275.SGD","LU1880383366.USD","BK4588","LU0672654166.SGD","SG9999001226.SGD","LU0149721374.USD","LU1303224171.USD","LU0163747925.USD","LU0417516902.SGD","IE0008368742.USD","09618","BK4524","HK0000320223.HKD","LU1044875133.USD","LU0244354667.USD","LU0231483743.USD","LU0211977185.USD","SGXZ62798434.SGD","BK1247","LU0228367735.SGD","BK4504","BK4614","LU0543330483.HKD","LU2242644610.SGD","LU0499858602.USD","LU1719994722.HKD","LU0791591158.USD","LU0791590937.USD","BK1502","LU1642822792.SGD","LU1044874839.SGD","LU0572944931.SGD","LU2039709279.SGD","SGXZ86797644.SGD","HK0000306685.HKD","LU1282649810.SGD","BK1249","LU0588545730.USD","BK4551","LU0051755006.USD","IE00BGV7N243.SGD","BK4122","LU0384037296.USD","LU0417516738.SGD","BK1571","BK1610","BK1615","LU0307460666.USD","LU0039217434.USD","LU1282651048.USD","BK4531","LU1188198961.HKD","LU1044876610.USD","JD","LU0327786744.USD","86618","LU1813983027.USD","LU1794554557.SGD","LU0293314216.USD","LU0348825331.USD","BK1142","LU1328277881.USD","BK4526","BK1575","LU0052750758.USD","LU0228659784.USD","LU1481107354.HKD","LU0865486749.SGD","LU1023057109.AUD","LU0828237510.HKD","LU0469268626.HKD","LU0359202008.SGD","LU1808992512.USD","LU0871576103.HKD","LU0359201612.USD","LU1224444064.USD","LU1366334651.USD","BK1588","LU0708995583.HKD","HK0000320264.USD","BK1591","LU0164865239.USD","BK1515","BK4505","LU0259732245.USD","LU0348805143.USD","BK4585","LU0650527681.SGD","LU0140636845.USD","SG9999002463.SGD","LU0588545490.SGD","LU0320764599.SGD","LU0106959298.USD","LU1251922891.USD","LU0315179316.USD","LU0431992006.USD","LU0345776255.USD","SG9999002828.SGD","LU0128522157.USD","LU0588546209.SGD","LU0456842615.SGD","89618","LU0314109678.HKD","LU0029875118.USD","LU1770036033.HKD","BK1619","LU0499858438.USD"],"gpt_icon":1},{"id":"1130164723","title":"CSPC Pharma Retains \"Outperform\" Rating with HK$13.07 Target from Haitong International","url":"https://stock-news.laohu8.com/highlight/detail?id=1130164723","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130164723?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:21","pubTimestamp":1772000468,"startTime":"0","endTime":"0","summary":"Haitong International has issued a research report stating that CSPC PHARMA's (01093) core business revenue and profits have bottomed out, with a return to a growth cycle expected by 2026. Starting...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","IE00BZ08YT58.USD","IE0008369823.USD","LU0067412154.USD","HK0000165453.HKD","LU1008478684.HKD","LU0072913022.USD","LU1807302812.USD","IE00B5MMRT66.SGD","LU1226288253.USD","LU0326950275.SGD","01093","SG9999004220.SGD","IE00B543WZ88.USD","LU1993786604.SGD","LU0880133367.SGD","IE0008368742.USD","LU0140636845.USD","LU1813983027.USD","LU0501845795.SGD","BK1191","LU1951186391.HKD","LU0314109678.HKD","BK1515","IE00BZ08YR35.GBP","LU1226287529.USD","LU2039709279.SGD","BK1521","LU1226287792.SGD","LU1226287875.USD","LU0315179316.USD","LU1152091754.HKD","LU1152091168.USD","LU1226288170.HKD","LU1960683339.HKD","IE00B031HY20.USD","LU1328277881.USD"],"gpt_icon":0},{"id":"1196731985","title":"Antengene-B Shares Surge Over 6% Following Clinical Collaboration Agreement with Junshi Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=1196731985","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196731985?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:20","pubTimestamp":1772000437,"startTime":"0","endTime":"0","summary":"Antengene-B (06996) rose more than 6%, with the stock up 6.4% to HK$3.66 at the time of writing, recording a turnover of HK$13.326 million. The company announced this morning that it has entered into...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","688180","BK4585","BK1574","VT","BK4588","VXUS","01877","BK0239","06996","BK1583","BK1191"],"gpt_icon":0},{"id":"2614577290","title":"Fosun Pharmaceutical Amends Drug Licensing Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2614577290","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614577290?lang=en_us&edition=fundamental","pubTime":"2026-02-25 13:39","pubTimestamp":1771997956,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (SHA:600196, HKG:2196) amended its licensing agreements for anti-cancer drug serplulimab.Subsidiary Henlius terminated its exclusive commercialization agreement with KGbi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0028","BK0183","BK0188","BK0175","02196","BK1515","BK0060","BK1191","BK1593","BK0096","BK0187","BK0239","BK0012","600196","BK0196"],"gpt_icon":0},{"id":"1191333349","title":"Waterdrop's Yifan Pharma Deploys China's First AI-Powered Patient Matching Patent for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1191333349","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191333349?lang=en_us&edition=fundamental","pubTime":"2026-02-25 13:14","pubTimestamp":1771996477,"startTime":"0","endTime":"0","summary":"Beijing Yifan Fengshun Pharmaceutical Technology Co., Ltd., a subsidiary of Waterdrop Inc., has recently been granted a national invention patent for its independently developed \"Intelligent Patient...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK4539","BK1574","BK1161","09939","BK4173","BK4509","159938","WDH"],"gpt_icon":0},{"id":"1105044209","title":"Liu Qiangdong Secures Five Yacht Orders Averaging 486 Million Yuan Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1105044209","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105044209?lang=en_us&edition=fundamental","pubTime":"2026-02-25 12:43","pubTimestamp":1771994614,"startTime":"0","endTime":"0","summary":"Liu Qiangdong has announced a personal investment of 5 billion yuan to enter the yacht industry, expressing his ambition to produce high-quality yachts priced around 100,000 yuan, making them as...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1575","HK0000320264.USD","LU0327786744.USD","BK4504","LU1770034418.SGD","LU0140636845.USD","JD","LU0029875118.USD","HK0000306685.HKD","LU0488056044.USD","LU0588545904.SGD","BK4579","LU0370786039.SGD","SG9999002828.SGD","LU1642822792.SGD","LU0211977185.USD","IE0008368742.USD","LU0463099449.HKD","LU1770036033.HKD","LU1282649810.SGD","IE00BGV7N243.SGD","BK1502","LU0417516902.SGD","LU0164880469.USD","LU0431992006.USD","SG9999002562.SGD","BK4220","SG9999002463.SGD","LU0359201885.HKD","BK4505","LU0588545490.SGD","LU0456827905.SGD","LU0650527681.SGD","LU1880383366.USD","LU1224444064.USD","LU2257852520.SGD","LU0051755006.USD","LU0164865239.USD","LU0469268626.HKD","BK1589","LU1813983027.USD","LU0345775950.USD","BK4122","LU2039709279.SGD","LU0588546209.SGD","LU1366334578.USD","LU0106959298.USD","BK4614","LU0039217434.USD","LU0791591158.USD","BK4503","LU0417516738.SGD","LU0672654166.SGD","LU0048580855.USD","BK4524","LU1719994722.HKD","LU0348735423.USD","LU0348825331.USD","LU0326950275.SGD","LU0871576103.HKD","LU1023057109.AUD","09618","BK4551","BK1247","BK4585","BK4558","LU0384037296.USD","LU0572944931.SGD","LU0052750758.USD","BK4509","LU0307460666.USD","LU1481107354.HKD","LU0228367735.SGD","IE0032431581.USD","BK1591","BK1583","LU0359202008.SGD","LU1251922891.USD","SG9999001226.SGD","BK1571","LU1366334651.USD","LU0315178854.USD","BK1619","LU2242644610.SGD","LU0228659784.USD","LU1188198961.HKD","IE00B29SXG58.USD","LU0865486749.SGD","LU1282651048.USD","LU0320764599.SGD","LU0259732245.USD","BK1515","LU1303224171.USD","LU0149721374.USD","LU1328277881.USD","LU0315179316.USD","SGXZ62798434.SGD","LU0293314216.USD","BK1610","KJD","BK4531","LU0128522157.USD","LU0320764755.SGD","LU0345776255.USD","LU0594300419.USD","HK0000320223.HKD","LU0868486357.SGD","LU0828237510.HKD","LU1720050803.USD","LU0499858438.USD","BK4588","IE00B3M56506.USD","LU1688375341.USD","BK1142","BK4526","LU0359201612.USD","LU0708995583.HKD","LU1282649067.USD","SGXZ86797644.SGD","BK1615","HK0000306701.USD","LU0231483743.USD","LU0348805143.USD","LU0531971595.HKD","LU0791590937.USD","LU1044875133.USD","LU0543330483.HKD","LU0244354667.USD","LU1282651121.HKD","LU0499858602.USD","LU0588545730.USD","LU1044876610.USD","LU0314109678.HKD","LU0456846285.SGD","LU1808992512.USD","BK1588","BK1249","86618","LU0084288322.USD","LU0456842615.SGD","89618","LU1794554557.SGD","LU1044874839.SGD","LU0163747925.USD"],"gpt_icon":1},{"id":"1163622937","title":"JPMorgan Increases Stake in SINOPHARM with Purchase of Approximately 347,233 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1163622937","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163622937?lang=en_us&edition=fundamental","pubTime":"2026-02-25 08:01","pubTimestamp":1771977687,"startTime":"0","endTime":"0","summary":"Recent data from the Hong Kong Stock Exchange indicates that on February 16, JPMorgan acquired an additional 347,233 shares of SINOPHARM (01099) at an average price of HK$21.4135 per share. The total...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","LU1115378108.SGD","LU2023250330.USD","LU0640476718.USD","LU2211815571.USD","LU2456880835.USD","LU0211326839.USD","LU1244550577.SGD","LU0820562030.AUD","LU0256863811.USD","LU0496365809.HKD","LU1988902786.USD","LU1670627923.USD","LU2237443622.USD","LU1244550221.USD","IE00BHPRN162.USD","LU1974910355.USD","LU1496350502.SGD","LU0943347566.SGD","LU1668664300.SGD","LU2023250504.SGD","LU2552382058.USD","LU0942090050.USD","IE00BDRTCR15.USD","LU2430703178.SGD","LU2505996509.AUD","LU1720051108.HKD","LU2381873111.SGD","LU1267930490.SGD","LU1548497426.USD","LU0265550359.USD","LU1917777945.USD","LU2462157665.USD","LU0689472784.USD","IE0034235295.USD","LU2417539215.USD","LU0211327993.USD","LU1116320901.HKD","IE0034235303.USD","LU0345769128.USD","IE00BN8TJ469.HKD","LU0976567544.SGD","LU1894683264.USD","LU0215105999.USD","LU0211326755.USD","IE00BBT3K403.USD","LU1914381329.SGD","01099","SG9999002232.USD","IE00BYXW3230.USD","BK4588","LU1280957306.USD","LU0683600562.USD","LU1496350171.SGD","IE00B1BXHZ80.USD","LU0106261372.USD","IE00BKVL7J92.USD","LU0820561818.USD","LU2237443978.SGD","BK4207","LU1670628061.USD","LU0251132253.USD","LU1162221912.USD","LU0345770993.USD","BK4566","LU1119994496.HKD","LU2213496289.HKD","BK4516","LU2430703095.HKD","LU0882574139.USD","LU2237443465.HKD","LU0048584097.USD","LU1084165304.USD","BK4550","LU1261432733.SGD","LU1366192091.USD","LU1032466523.USD","LU0234572021.USD","LU0203347892.USD","JPMO","LU0640798160.USD","IE00BZ1G4Q59.USD","LU1145028129.USD","LU1363072403.SGD","IE00B1XK9C88.USD","LU2237443549.SGD","LU2236285917.USD","LU2023250843.SGD","LU0149725797.USD","IE00BJTD4N35.SGD","LU1244550494.USD","BK1500","LU1720051017.SGD","BK1515","IE00B775SV38.USD","IE00B3S45H60.SGD","LU0323591593.USD","LU0203345920.USD","BK4585","BK1197","LU0211331839.USD","JPM","LU0211328371.USD","IE00BDCRKT87.USD","LU1116320737.USD","LU1629891620.HKD","IE00BLSP4239.USD","LU0820561909.HKD","LU2237443382.USD","LU2552382132.HKD","IE000M9KFDE8.USD","LU0320765489.SGD","LU0320765646.SGD","LU0417517546.SGD","LU0868494617.USD","LU2746668974.SGD","BK4533","IE00BJLML261.HKD","LU2054465674.USD","LU0006306889.USD","LU0868494708.USD","LU0964807845.USD","LU2746668461.USD","IE00BJTD4V19.USD","LU0208291251.USD","LU2592432038.USD","LU2756315664.SGD","LU0170899867.USD","LU0238689110.USD","LU1064131342.USD","LU2242649171.HKD","LU0070302665.USD","IE0034235188.USD","LU0345769631.USD","LU0787776722.HKD","LU2552382215.SGD","LU1894683348.USD","LU0267386448.USD","LU2237443895.HKD","LU2357305700.SGD","IE00BLSP4452.SGD","LU0310799852.SGD","BK4534","BK4581","LU2264538146.SGD","LU0345770308.USD","LU0265550946.USD","LU1551013342.USD","SG9999002224.SGD","LU0971096721.USD","LU2756315318.SGD","IE00BKDWB100.SGD","LU0106831901.USD","BK4504","IE00BFXG1179.USD","LU2505996681.GBP","LU2430703251.USD","LU1551013425.SGD","IE00BWXC8680.SGD"],"gpt_icon":1},{"id":"1121856522","title":"Pharmaceutical Licensing Deals Surge as Domestic R&D Capabilities Strengthen","url":"https://stock-news.laohu8.com/highlight/detail?id=1121856522","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121856522?lang=en_us&edition=fundamental","pubTime":"2026-02-25 07:13","pubTimestamp":1771974813,"startTime":"0","endTime":"0","summary":"The pharmaceutical sector is experiencing a surge in business development activity following the Lunar New Year holiday. On February 24, the first trading day after the break, Frontier...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159938","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"1159534204","title":"CANSINOBIO's Meningococcal Vaccine Menhycyte™ Receives Expanded Age Indication Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1159534204","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159534204?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:46","pubTimestamp":1771922808,"startTime":"0","endTime":"0","summary":"CANSINOBIO (06185) announced that it has received a Supplemental Drug Application Approval Notice from the National Medical Products Administration (NMPA). According to the notice, the NMPA has...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1191","BK1574","BK1515","06185"],"gpt_icon":0},{"id":"2613943795","title":"JD Health International Stock Falls 2.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2613943795","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613943795?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:33","pubTimestamp":1771921980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. slid 2.1% to 56.90 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.8% to 26590.32.JD Health International Inc. closed 21% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 7.7 million shares, compared to the 50-day average of 7.4 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4558","BK1615","LU0326950275.SGD","IE00BGV7N243.SGD","BK1571","HK0000306685.HKD","KJD","SGXZ86797644.SGD","IE0008368742.USD","BK4614","BK4220","BK4505","BK4526","HK0000320223.HKD","LU0588546209.SGD","LU0463099449.HKD","BK4509","BK4504","06618","SGXZ62798434.SGD","LU0307460666.USD","BK1591","86618","BK4122","BK4503","LU0456827905.SGD","HK0000306701.USD","LU1688375341.USD","LU0106959298.USD","HK0000320264.USD","BK4588","LU0051755006.USD","BK1515","BK4579","BK1589","BK1247","BK4524","BK4551","BK1142","BK4531","BK1583","LU0244354667.USD","LU1880383366.USD","BK4585","LU1188198961.HKD","SG9999002463.SGD"],"gpt_icon":1},{"id":"2613687795","title":"CSPC Pharmaceutical Group Stock Slips 5.2% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2613687795","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613687795?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:31","pubTimestamp":1771921860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. shed 5.2% to 10.06 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.8% to 26590.32.The stock's fall snapped a three-day winning streak.CSPC Pharmaceutical Group Ltd. closed 13% below its 52-week high of HK$11.63, which the company reached Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 6.6%, SSY Group Ltd. rose 0.3%, and United Laboratories International Holdings Ltd. fell 3.3%.Trading volume totaled 102.2 million shares, compared to the 50-day average of 127.4 million shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","LU1226288170.HKD","LU1226287529.USD","LU1813983027.USD","IE00BZ08YR35.GBP","LU1226287792.SGD","IE00BZ08YT58.USD","LU1008478684.HKD","IE00B543WZ88.USD","LU2039709279.SGD","LU1152091168.USD","LU0501845795.SGD","LU0880133367.SGD","LU0072913022.USD","LU1226287875.USD","BK1521","HK0000165453.HKD","LU0067412154.USD","IE0008369823.USD","BK1515","LU0314109678.HKD","LU0315179316.USD","IE00B5MMRT66.SGD","LU0140636845.USD","SG9999004220.SGD","BK1191","LU1328277881.USD","LU0326950275.SGD","LU1960683339.HKD","01093","LU1993786604.SGD","LU1152091754.HKD","LU1951186391.HKD","LU1226288253.USD","IE0008368742.USD","LU1807302812.USD","IE00B031HY20.USD"],"gpt_icon":0},{"id":"2613572795","title":"Sino Biopharmaceutical Stock Slides 6.6% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2613572795","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613572795?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:31","pubTimestamp":1771921860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 6.6% to 6.39 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.8% to 26590.32.The stock's fall snapped a three-day winning streak.Sino Biopharmaceutical Ltd. closed 30% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 5.2% and Amgen Inc. remained unchanged.Trading volume totaled 91.3 million shares, compared to the 50-day average of 62.2 million shares.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","HK0000165453.HKD","IE00BZ08YT58.USD","BK1589","BK1191","01177","IE00BZ08YR35.GBP","BK1515","BK1521"],"gpt_icon":0},{"id":"2613793067","title":"CSPC Pharma's AstraZeneca Deal Suggests Undervalued Drug Pipeline -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2613793067","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613793067?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:25","pubTimestamp":1771921500,"startTime":"0","endTime":"0","summary":"0825 GMT - The size of CSPC Pharmaceutical's deal struck with AstraZeneca last month beat CGS International's expectations and implies the Chinese company's drug pipeline is undervalued, analyst Vicky Zhu says. She notes that the pharmaceutical company has around 90 innovative drugs in its pipeline at various clinical stages. CSPC's revenue is expected to recover from 2026, as the drag from volume-based procurement price cuts is likely to have been digested in 2025, Zhu adds in a note. CGSI raises its target price to HK$11.63 from HK$11.12 and retains an add rating on CSPC Pharma, which ends 5.2% lower at HK$10.06. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CSPC Pharma's AstraZeneca Deal Suggests Undervalued Drug Pipeline -- Market Talk","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1951186391.HKD","LU1993786604.SGD","LU1813983027.USD","LU0067412154.USD","LU0501845795.SGD","HK0000165453.HKD","LU1226287529.USD","IE00B543WZ88.USD","LU0314109678.HKD","IE00B031HY20.USD","LU1328277881.USD","LU1807302812.USD","IE0008368742.USD","LU2039709279.SGD","LU1226288253.USD","LU0880133367.SGD","IE00B5MMRT66.SGD","LU1226287792.SGD","LU0315179316.USD","LU1152091168.USD","BK1191","BK1515","LU0072913022.USD","SG9999004220.SGD","LU0140636845.USD","01093","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK1521","LU1226287875.USD","LU1152091754.HKD","LU1008478684.HKD","LU1960683339.HKD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1226288170.HKD","IE0008369823.USD"],"gpt_icon":0},{"id":"1179077937","title":"AH Premium Rankings for February 24th","url":"https://stock-news.laohu8.com/highlight/detail?id=1179077937","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179077937?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:21","pubTimestamp":1771921291,"startTime":"0","endTime":"0","summary":"As of the market close on February 24th, NE ELECTRIC (00042), JINGCHENG MAC (00187), and Sinopec Oilfield Service (01033) recorded the highest AH share premium rates, at 757.14%, 285.62%, and 282.18%...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1105","HK0000352382.USD","LU0348788117.USD","LU0043850808.USD","LU1211504680.USD","LU0516423174.USD","LU0531970944.HKD","LU0348827113.USD","LU0502904849.HKD","LU1282649810.SGD","BK1552","LU1152091168.USD","IE0031814852.USD","LU1008478684.HKD","BK1515","LU0163747925.USD","LU2153592121.USD","LU0266512473.USD","LU0823039010.USD","IE00BVYPNQ40.USD","SG9999002463.SGD","LU0819121731.USD","BK1543","LU0588545730.USD","LU0572940350.SGD","IE00B0169L03.USD","LU0469268626.HKD","LU0634319403.HKD","LU0181495838.USD","LU0143863784.USD","IE00B3M56506.USD","HK0000306685.HKD","BK1231","BK1562","LU2399975544.HKD","00042","BK1140","LU0456827905.SGD","IE00BYV24P56.USD","IE00B031HY20.USD","LU1880383366.USD","LU0289960550.SGD","LU0821914370.USD","LU0096374516.USD","LU0084288322.USD","LU0329678170.USD","002594","BK1229","LU0164865239.USD","LU2476274720.SGD","LU0320764599.SGD","LU2097828714.EUR","BK1191","LU1868838027.USD","LU0823426308.USD","IE00BZ08YT58.USD","81211","LU0214875030.USD","LU0865486749.SGD","LU0269904917.USD","BK1550","LU0348735423.USD","LU0039217434.USD","LU0266512127.USD","LU0370786039.SGD","LU0594300179.USD","LU0856984785.SGD","LU0880133367.SGD","LU2360107325.USD","LU1769817179.HKD","LU2039709279.SGD","LU0164880469.USD","LU1880383440.USD","399300","BYDDY","LU2097828474.EUR","HYDD.SI","LU0511384066.AUD","SG9999014674.SGD","LU1960683339.HKD","HK0000306701.USD","BK1592","LU0359201612.USD","LU0516422440.USD","LU2778985437.USD","LU0149721374.USD","LU0594300419.USD","SG9999006514.SGD","LU0979878070.USD","LU0229945570.USD","LU1188198961.HKD","LU0620787316.HKD","LU0164939612.USD","BK1537","LU0456854461.SGD","LU0455707207.USD","LU1328277881.USD","LU0488056044.USD","LU0417516571.SGD","LU0348783233.USD","LU0868486357.SGD","BK1223","BK1183","LU0543330566.HKD","SG9999002828.SGD","LU0456846285.SGD","LU0737861772.HKD","LU0211977185.USD","IE00BZ08YR35.GBP","LU0254981946.USD","IE00BF5LJ272.USD","BK1237","BK1563","LU0708995583.HKD","LU0231483743.USD","BK1540","LU0588546209.SGD","LU0791591158.USD","BK1184","LU0051755006.USD","BK1507","LU0106959298.USD","LU1224709979.USD","LU0828238088.HKD","00187","LU0886674414.USD","LU2097828557.USD","LU0431992006.USD","LU0328353924.USD","BK1528","BK1174","LU1366334651.USD","LU0259732245.USD","LU0359201885.HKD","BK1163","LU0244354667.USD","BK1202","LU0505663152.USD","BK1224","LU0052750758.USD","IE0034224299.USD","LU1808992512.USD","LU0540923850.HKD","LU0588545904.SGD","LU2125910500.SGD","LU1720050803.USD","LU0048580855.USD","BK1198","LU0890818403.SGD","LU0348825331.USD","LU0348784397.USD","LU0823414478.USD","LU2097828631.EUR","LU0359202008.SGD","LU0509642566.USD","HK0000320223.HKD","BK1171","BK1583","LU1868837565.USD","LU0516422366.SGD","LU1105468828.SGD","LU0791590937.USD","BK1522","LU2506951792.HKD","LU0326950275.SGD","IE00B031J352.USD","LU0593848301.USD","LU0165289439.USD","LU0314109678.HKD","IE00B543WZ88.USD","LU0327786744.USD","BK1576","LU0918141887.USD","LU0264606111.USD","LU0287142896.SGD","LU0737861699.HKD","BK1214","LU0516423091.SGD","LU1675838814.USD","LU1961090484.USD","LU2357125470.USD","LU0067412154.USD","LU2045819591.USD","LU1719994722.HKD","LU0329678337.USD","LU0823414551.USD","LU0307460666.USD","LU1794554557.SGD","159982","BK1112","LU0417516902.SGD","LU1366334578.USD","BK1521","LU0828237940.HKD","BK1560","LU0640798160.USD","LU0449509016.USD","LU1048596156.SGD","LU1251922891.USD","LU0561508036.HKD","LU0650527681.SGD","LU0315178854.USD","IE00BPRC5H50.USD","BK1610","LU1831875114.USD","BK1546","IE0008369823.USD","LU0589944569.HKD","LU0228367735.SGD","LU1813983027.USD","LU0516422952.EUR","BK1135","LU1303224171.USD","BK1594","LU0082770016.SGD","LU0572944931.SGD","03143","BK1582","LU3063872942.SGD","IE00BD6J9T35.USD","LU0117841782.USD","LU0871576103.HKD","LU0449515922.USD","LU0348805143.USD","BK1564","LU0588545490.SGD","LU0823426480.USD","LU0164872284.USD","LU0345780521.USD","LU1226287529.USD","HK0000320264.USD","LU2348774022.SGD","LU1861219969.SGD","LU0049853897.USD","IE00BVYPNP33.GBP","LU0572939691.SGD","BK1554","LU1242518931.SGD","LU0348816934.USD","LU0072913022.USD","LU1770034418.SGD","BK1509","LU1993786604.SGD","LU2449936058.SGD","SG9999015986.USD","BK1149","BK1551","BK1205","BK1544","LU1688375341.USD","LU0648948544.HKD","BK1258","LU0828237510.HKD","LU0862451753.SGD","600860","LU1481107354.HKD","LU0061477393.USD","SG9999001226.SGD","LU1152091754.HKD","LU2249611893.SGD","IE00BGHQDM52.EUR","SG9999004220.SGD","IE00B29SXG58.USD","LU0501845795.SGD","LU0082770016.USD","BK1584","LU1504937902.USD","SG9999015978.USD","BK1503","LU0823038988.USD","LU1282649067.USD","BK1574","LU1807302812.USD","LU2294711713.HKD","LU0228659784.USD","IE0008368742.USD","LU0143863198.USD","BK1119","SG9999015945.SGD","BK1161","LU0054450605.USD","LU0531971595.HKD","IE00BZ08YS42.EUR","LU1282648689.USD","LU1023057109.AUD","LU1769817096.USD","LU0140636845.USD","LU0175139822.USD","LU0797268264.HKD","LU0463099449.HKD","LU0605514214.HKD","LU1046422090.SGD","LU1115378108.SGD","LU1868837722.USD","LU0289739343.SGD","BK1147","LU0289961442.SGD","BK1116","LU0345780281.USD","BK1501","LU2097828805.USD","LU2226246903.HKD","IE00BMCWC346.EUR","IE00B5MMRT66.SGD","LU2476274308.USD","BK1505","LU1282649141.HKD","LU1242518857.USD","LU0819123356.HKD","LU0417516738.SGD","BK1514","LU0384037296.USD","LU0348814723.USD","LU0315179316.USD","HK0000352291.HKD","BK1539","LU2242644610.SGD","LU0106252389.USD","SG9999015952.SGD","BK1240","LU0173614495.USD","SG9999006597.SGD","LU1861214812.USD","LU0918141705.HKD","BK1141"],"gpt_icon":0},{"id":"1152132520","title":"Zhejiang Medicine to Invest in Partnership Fund Targeting Silver Economy and Healthcare Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1152132520","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152132520?lang=en_us&edition=fundamental","pubTime":"2026-02-24 15:57","pubTimestamp":1771919826,"startTime":"0","endTime":"0","summary":"Zhejiang Medicine Co.,Ltd. (600216.SH) announced that on February 24, 2026, the company signed a partnership agreement with general partner CITIC Healthcare Equity Investment Private Fund Management...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1161","BK0188","BK0028","09939","BK0239","BK0191","BK1515","BK1574","600216"],"gpt_icon":0},{"id":"2613083972","title":"Xuanzhu Biopharmaceutical to Join Hang Seng Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2613083972","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613083972?lang=en_us&edition=fundamental","pubTime":"2026-02-23 10:01","pubTimestamp":1771812091,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group  said its non-wholly owned subsidiary Xuanzhu Biopharmaceutical  is due for inclusion to the Hang Seng Composite Index on March 9, according to a Hong Kong bourse filing Friday.Xuanzhu Biopharmaceutical went public in Hong Kong in October of last year.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1593","BK1515","00460","02575","BK1600","BK1191"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":77,"code":"91000000","status":"200"}]}}